NZ320522A - Piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same and a process for the preparation of the compounds - Google Patents
Piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same and a process for the preparation of the compoundsInfo
- Publication number
- NZ320522A NZ320522A NZ320522A NZ32052296A NZ320522A NZ 320522 A NZ320522 A NZ 320522A NZ 320522 A NZ320522 A NZ 320522A NZ 32052296 A NZ32052296 A NZ 32052296A NZ 320522 A NZ320522 A NZ 320522A
- Authority
- NZ
- New Zealand
- Prior art keywords
- preparation
- pct
- pharmaceutical compositions
- compositions containing
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000009543 pathological alteration Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/38—One sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9503099A HUT76266A (en) | 1995-10-31 | 1995-10-31 | New piperazinyl-alkylthio-pyrimidine derivatives, pharmaceutical compositions containing them, and process for producing the active components |
| PCT/HU1996/000061 WO1997016429A1 (en) | 1995-10-31 | 1996-10-25 | Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same and a process for the preparation of the novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ320522A true NZ320522A (en) | 1999-03-29 |
Family
ID=10987317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ320522A NZ320522A (en) | 1995-10-31 | 1996-10-25 | Piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same and a process for the preparation of the compounds |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6130215A (cs) |
| EP (1) | EP0901473B1 (cs) |
| JP (1) | JPH11514641A (cs) |
| KR (1) | KR19990067137A (cs) |
| CN (1) | CN1207733A (cs) |
| AT (1) | ATE214375T1 (cs) |
| AU (1) | AU707166B2 (cs) |
| CZ (1) | CZ112198A3 (cs) |
| DE (1) | DE69619868T2 (cs) |
| HU (1) | HUT76266A (cs) |
| NZ (1) | NZ320522A (cs) |
| PL (1) | PL327461A1 (cs) |
| SK (1) | SK283489B6 (cs) |
| WO (1) | WO1997016429A1 (cs) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4425143A1 (de) * | 1994-07-15 | 1996-01-18 | Basf Ag | Substituierte Pyrimidinverbindungen und deren Verwendung |
| CA2376307A1 (en) * | 1999-06-29 | 2001-01-04 | Egis Gyogyszergyar Rt. | Novel piperazinylalkylthiopyrimidine derivatives,pharmaceutical composi tions containing the same,and a process for the preparation of the active substance |
| US20040014966A1 (en) * | 2000-06-20 | 2004-01-22 | Jacobsen Eric Jon | Bis-arylsulfones |
| US6586592B2 (en) | 2000-06-20 | 2003-07-01 | Pharmacia & Upjohn Company | Bis-arylsulfones |
| PE20020063A1 (es) | 2000-06-20 | 2002-01-30 | Upjohn Co | Bis-arilsulfonas como ligandos del receptor de 5-ht |
| DE112009001776B4 (de) | 2008-07-30 | 2021-01-21 | Asahi Kasei Chemicals Corporation | Verfahren zur Herstellung von Cycloolefin und Vorrichtung zur Herstellung desselben |
| US10315655B2 (en) | 2017-03-07 | 2019-06-11 | Deere & Company | Vehicle control based on soil compaction |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE792206A (cs) * | 1971-12-02 | 1973-06-01 | Byk Gulden Lomberg Chem Fab | |
| JPS61271278A (ja) * | 1985-05-20 | 1986-12-01 | イ− ア−ル スクイブ アンド サンズ インコ−ポレ−テツド | ２−置換チオまたはオキソ−４−アリ−ルまたはヘテロシクロ−５−カルボキシ−１，４−ジヒドロピリミジン |
-
1995
- 1995-10-31 HU HU9503099A patent/HUT76266A/hu unknown
-
1996
- 1996-10-25 SK SK475-98A patent/SK283489B6/sk unknown
- 1996-10-25 JP JP9517175A patent/JPH11514641A/ja active Pending
- 1996-10-25 DE DE69619868T patent/DE69619868T2/de not_active Expired - Fee Related
- 1996-10-25 US US09/066,465 patent/US6130215A/en not_active Expired - Fee Related
- 1996-10-25 AU AU73262/96A patent/AU707166B2/en not_active Ceased
- 1996-10-25 KR KR1019980703083A patent/KR19990067137A/ko not_active Withdrawn
- 1996-10-25 CZ CZ981121A patent/CZ112198A3/cs unknown
- 1996-10-25 EP EP96935194A patent/EP0901473B1/en not_active Expired - Lifetime
- 1996-10-25 NZ NZ320522A patent/NZ320522A/xx unknown
- 1996-10-25 WO PCT/HU1996/000061 patent/WO1997016429A1/en not_active Ceased
- 1996-10-25 CN CN96198654A patent/CN1207733A/zh active Pending
- 1996-10-25 AT AT96935194T patent/ATE214375T1/de not_active IP Right Cessation
- 1996-10-25 PL PL96327461A patent/PL327461A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US6130215A (en) | 2000-10-10 |
| HUT76266A (en) | 1997-07-28 |
| SK283489B6 (sk) | 2003-08-05 |
| KR19990067137A (ko) | 1999-08-16 |
| HU9503099D0 (en) | 1995-12-28 |
| ATE214375T1 (de) | 2002-03-15 |
| SK47598A3 (en) | 1998-12-02 |
| EP0901473B1 (en) | 2002-03-13 |
| WO1997016429A1 (en) | 1997-05-09 |
| AU7326296A (en) | 1997-05-22 |
| JPH11514641A (ja) | 1999-12-14 |
| DE69619868D1 (de) | 2002-04-18 |
| PL327461A1 (en) | 1998-12-07 |
| EP0901473A1 (en) | 1999-03-17 |
| CZ112198A3 (cs) | 1998-09-16 |
| AU707166B2 (en) | 1999-07-01 |
| CN1207733A (zh) | 1999-02-10 |
| DE69619868T2 (de) | 2002-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT72436A (en) | Process for the production of imidazopyridines and pharmaceutical compositions containing them and which are suitable for treating gastro-intestinal diseases | |
| ZA953469B (en) | New compound | |
| LU91145I9 (cs) | ||
| TNSN97145A1 (fr) | Derives 6,5-heterobicycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| TW263499B (cs) | ||
| GR3017996T3 (en) | 17-g(b)-SUBSTITUTED-4-AZA-5-g(a)-ANDROSTAN-3-ONE DERIVATIVES AND PROCESS FOR THEIR PREPARATION. | |
| MA27676A1 (fr) | 2-amino-6-(2-substitue-4-phenoxy)-substitue-pyridines, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| HU9602413D0 (en) | Novel tetrasubstituted imidazole derivatives, method for preparing same, resulting novel intermediates, use thereof as drugs, and pharmaceutical compositions containing same | |
| IL122706A0 (en) | N-(4-substituted-benzyl)-2-aminolactam derivatives their preparation and pharmaceutical compositions containing them | |
| IL113365A0 (en) | 5-heterocyclo-1,5-benzodiazepine derivatives, their preparation and use and pharmaceutical compositions containing them | |
| ES2006619A6 (es) | Un metodo para preparar derivados de piridil-y pirimidil-piperazinas. | |
| IL122974A (en) | Optionally substituted tetrahydro-1H-naph[1,2,3-de]isoquinoline and pharmaceutical compositions containing them | |
| NZ320522A (en) | Piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same and a process for the preparation of the compounds | |
| AU5644296A (en) | Novel heterocyclic chemistry | |
| FR2724933B1 (cs) | ||
| BR9610175A (pt) | Composto processo de preparação do composto composição farmacêutica e utilização do composto | |
| TW371661B (en) | Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides | |
| IL108290A0 (en) | Pyrrolidine derivatives, their preparation and medicaments containing them | |
| IL117083A (en) | Pyridine and pyridazine derivatives processes for the production thereof and pharmaceutical compositions containing these compounds | |
| ZA944317B (en) | New phosphonosuccinic acid derivatives processes for the preparation thereof and pharmaceutical compositions containing them | |
| MY138319A (en) | 1,5-benzodiazepine derivatives | |
| AU5768298A (en) | Use of benzoylalkyl-1,2,3,6-tetrahydropyridins | |
| AU2796695A (en) | Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders |